Clinical Trial Update: Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating melatonin for sleep disturbances in Parkinson's disease; the current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: KIMJisun | Conditions: Parkinson's Disease | Phase 4 | Status: UNKNOWN